Home・Aandelen Lijst・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Gesloten

SectorGezondheidszorg

564.36 -1.62

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

572

Max

583.39

Belangrijke statistieken
By Trading Economics
Inkomsten	85M 1.7B
Verkoop	989M 12B
K/W Sectorgemiddelde	30.575 64.641
EPS	6.03
Dividendrendement	0.15
Winstmarge	14.516
Werknemers	125,000
EBITDA	262M 2.6B

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+6.98% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	0.15% 2.31%
Volgende Winsten	21 okt 2026
Volgende dividenddatum	15 okt 2026
Volgende Ex Dividend datum	15 sep 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	17B 213B
Vorige openingsprijs	565.98
Vorige sluitingsprijs	564.36

Nieuwssentiment

By Acuity

24%

76%

67 / 340 Rangschikking in Healthcare

Thermo Fisher Scientific Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 aug 2026, 19:26 UTC

Thermo Fisher Scientific Inc. shares are higher today, tracking broader market gains amid falling energy prices and renewed investor confidence. No specific company news identified.

1 aug 2026, 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

31 jul 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30 jul 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29 jul 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28 jul 2026, 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27 jul 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24 jul 2026, 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23 jul 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22 jul 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21 jul 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20 jul 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Peer Vergelijking

Prijswijziging

Thermo Fisher Scientific Inc Prognose

Koersdoel

By TipRanks

6.98% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 614.41 USD 6.98%

Hoogste 690 USD

Laagste 520 USD

Gebaseerd op 19 Wall Street-analisten die 12-maands prijsdoelen bieden voor Thermo Fisher Scientific Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

19 ratings

Buy

Hold

Sell

Gebaseerd op 19 analisten die aandelenratings hebben gegeven aan Thermo Fisher Scientific Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

67 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar